Covagen

Covagen is an organization that specializes in developing protein-based therapeutics for the treatment of inflammatory diseases and cancer. They achieve this by fusing their human Fynomer binding proteins to antibodies, resulting in bispecific FynomAbs with novel modes of action and enhanced efficacy. Their goal is to access novel biology for each product candidate, and their lead FynomAb COVA322 ...